Viridian seeks Priority Review for veligrotug, aiming for a potential mid-2026 commercial launch if approved. Global phase 3 ...

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...

Dear Doctors: Lately, we’ve been seeing a lot of ads on TV for a medication to treat thyroid eye disease. My daughter, who is 23, suffers from dry eyes, and now she’s sure she has it. What is thyroid ...

“Over the past few years, with the advent of pharmaceutical therapy for thyroid eye disease, it’s a little more in the forefront. With the marketing and ads on TV, it’s become more commonly discussed, ...

Researchers in Korea recently identified predictive factors for normalization of thyroid-stimulating immunoglobulin levels in moderate-to-severe Graves’ orbitopathy, highlighting the importance of ...

People with thyroid eye disease receiving infusions of the insulin-like growth factor-1 receptor veligrotug report improved ...

Doses of Tepezza are given by an intravenous infusion through a blood vessel in your arm. This infusion is usually given at a hospital, health care provider’s office, or infusion center. Sometimes you ...

Please provide your email address to receive an email when new articles are posted on . PCPs should work alongside specialists when treating thyroid eye disease, an expert told Healio. They may need ...

Thyroid eye disease (TED) is complicated, with symptoms that can vary from person to person. It’s not widely understood — even by healthcare providers in some cases. Research indicates that it’s ...